导管切除与抗心律失常药物治疗心房动:A4研究
Pierre Jaïs1, Bruno Cauchemez, Laurent Macle
1Hôpital Cardiologique du Haut-Lévêque, Avenue de Magellan, 33604 Bordeaux-Pessac, France. pierre.jais@chu-bordeaux.fr
Circulation
|November 26, 2008
概括
导管切除在治疗心房动 (AF),维持鼻节律和改善患者生活质量方面优于抗心律失常药物. 这项研究比较了帕洛西斯马性AF患者的切除和药物策略.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
背景情况:
- 药物治疗是心房动 (AF) 的首要治疗方法.
- 在过去的十年中,导管切除已经成为AF的重要替代治疗方法.
- 对这两种策略的疗效进行比较研究是有限的.
研究的目的:
- 为了比较导管切除与抗心律失常药物的有效性,在患有 Paroxysmal 心房的患者中.
- 评估两种治疗策略的长期结果,包括症状负担和生活质量.
主要方法:
- 一个随机的多中心试验,涉及患有抗心律不良药物耐药的偏激性AF患者.
- 患者被随机分配到导管切除 (肺静脉隔离) 或新的抗失常药物治疗中.
- 评估的结果包括AF的复发,需要药物改变,症状得分,运动能力,生活质量和AF负担在3,6和12个月.
主要成果:
- 这项研究招募了112名患者,随机分别接受了切除 (n=53) 或抗失常药物 (n=59).
- 在1年的随访中,89%的废除组患者没有复发AF,而抗心律药物组的这一比例为23% (P<0.0001).
- 经过切除术的患者在症状得分,运动能力和生活质量方面显著改善.
结论:
- 导管切除比抗不律性药物更有效地维持阴道节律在患有偏发性AF的患者.
- 与药物治疗相比,导管切除显著改善症状,运动能力和生活质量.
- 这项研究支持导管切除作为精选AF患者的优越治疗策略.
相关概念视频
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Disturbances in Heart Rhythm
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...


